Cite

HARVARD Citation

    Reagan, P. et al. (n.d.). HIGH RATE OF MORBID CENTRAL LINE ASSOCIATED COMPLICATIONS DURING TREATMENT WITH DOSE‐ADJUSTED R‐EPOCH THERAPY FOR NON‐HODGKIN LYMPHOMA. Hematological oncology. pp. 413-414. [Online]. 
  
Back to record